The global market leader in polyisoprene rubber latex for medical end markets, Cariflex broke ground at a 6.1 hectares site in Jurong Island, Singapore.

Cariflex will be constructing the world's largest and Singapore's first polyisoprene latex plant on this site. Driven by a strong commitment to better serve its global customers in medical and consumer products, this investment represents the largest capacity expansion in Cariflex's existing accomplishments.

Cariflex's polyisoprene rubber latex (Cariflex™ IR Latex) is a synthetic, water-based polymer latex, suitable for a wide range of high value applications. Surgical gloves and condoms represent the key end markets that Cariflex™ IR Latex are used for, on account of its unique value proposition as an alternative to natural rubber latex.

The Singapore plant will play a vital role in Cariflex's manufacturing supply versatility to serve their customers in Southeast Asia, where the world's key manufacturing plants of surgical gloves and condoms are located.

The company successfully completed its latest major expansion in 2021, doubling its polyisoprene latex capacity at the Paulinia Facility, Brazil, with an investment of $50M.